Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comparative pathogenicity study of monkeypox virus Clade Ib and Clade IIb in a rabbit model.

Created on 24 Sep 2026

Authors

Sreelekshmy Mohandas, Abhimanyu Kumar, Deepak Mali, Rajlaxmi Jain, Vishal Rajput, Deepak Y Patil, Pragya Yadav

Published in

Virulence. Volume 17. Issue 1. Pages 2728484. Epub Sep 23, 2026.

Abstract

Mpox has emerged as a significant public health concern, spreading across continents with the emergence of new variants. Clade IIb, from the recent global outbreak, and the newly identified Clade Ib have shown changes in transmission dynamics and possibly in severity. We developed a New Zealand White rabbit model of Mpox by using a combination of intradermal and intravenous routes of administration. Following infection, the rabbits developed erythematous papular lesions on the skin, which progressed to crust and scab formation by the second week, ultimately leading to healing and seroconversion. Infection with the Clade Ib and IIb.A.2.1 lineages revealed that both Monkeypox virus (MPXV) variants caused skin and testicular lesions, as well as viral excretion from the nasal cavity, skin, and testicular tissue. However, there were no significant differences in disease severity between the two variants. These findings suggest that this rabbit model could be useful for evaluating countermeasures against MPXV.

PMID:
42778521
Bibliographic data and abstract were imported from PubMed on 24 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 22
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement